title: Ex vivo hepatocyte gene therapy: increased biosafety protocol for transduction in suspension with lentiviral vectors and immediate transplantation (SLIT).
authors.forename: Jacques
authors.initials: J
authors.lastname: Birraux
authors.forename: Barbara E
authors.initials: BE
authors.lastname: Wildhaber
authors.forename: Caty
authors.initials: C
authors.lastname: Jond
authors.forename: Dominique C
authors.initials: DC
authors.lastname: Belli
authors.forename: Olivier
authors.initials: O
authors.lastname: Menzel
mesh_terms: D000818:Animals; D002470:Cell Survival; D003264:Containment of Biohazards / Q000379:methods; D015316:Genetic Therapy / Q000379:methods*; D022781:Hepatocytes / Q000166:cytology / Q000637:transplantation* / Q000821:virology; D006801:Humans; D016180:Lentivirus Infections / Q000517:prevention & control* / Q000635:transmission; D008107:Liver Diseases / Q000601:surgery*; D016031:Liver Transplantation / Q000379:methods / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D057057:Serine Proteases / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014357:Trypsin / Q000627:therapeutic use
chemical_list: D057057:Serine Proteases; D014357:Trypsin